← Back to Search

Lymphatic OMM for COVID-19

N/A
Waitlist Available
Research Sponsored by Rowan University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Inclusion criteria will include age greater than 18 years old and having safely received the COVID-19 vaccine.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the day of first vaccine dose (baseline), the day of second vaccine dose (at about 4-weeks post first vaccine dose), and 2-weeks post second vaccine dose (at about 6-weeks post first vaccine dose
Awards & highlights

Study Summary

This trial will study if Osteopathic Manipulative Medicine treatments can help improve antibody response in people who have received the Moderna COVID-19 vaccine.

Eligible Conditions
  • COVID-19
  • Coronavirus

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the day of first vaccine dose (baseline), the day of second vaccine dose (at about 4-weeks post first vaccine dose), and 2-weeks post second vaccine dose (at about 6-weeks post first vaccine dose
This trial's timeline: 3 weeks for screening, Varies for treatment, and the day of first vaccine dose (baseline), the day of second vaccine dose (at about 4-weeks post first vaccine dose), and 2-weeks post second vaccine dose (at about 6-weeks post first vaccine dose for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
severe acute respiratory syndrome-associated coronavirus 2 (SARS-Cov-2) antibody levels

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Lymphatic OMM plus Moderna COVID-19 Vaccine regimenExperimental Treatment1 Intervention
Patients receive OMM treatments that will include thoracic inlet and outlet myofascial release, pectoral traction myofascial release, and Miller Thoracic Lymphatic Pump technique plus the Moderna COVID-19 Vaccine regimen.
Group II: Light Touch plus Moderna COVID-19 Vaccine regimenPlacebo Group1 Intervention
Patients receive a series of light touch techniques plus the Moderna COVID-19 Vaccine regimen.

Find a Location

Who is running the clinical trial?

Rowan UniversityLead Sponsor
23 Previous Clinical Trials
2,865 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Lymphatic Osteopathic Manipulative Medicine to Enhance Coronavirus (COVID-19) Vaccination Efficacy
2021. "Lymphatic Osteopathic Manipulative Medicine to Enhance Coronavirus (COVID-19) Vaccination Efficacy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05069636.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top